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Abstract High field MRI operating at 3 T is increasingly
being used in the field of neuroradiology on the grounds that
higher magnetic field strength should theoretically lead to a
higher diagnostic accuracy in the diagnosis of several disease
entities. This Editorial discusses the exhaustive review by
Wardlaw and colleagues of research comparing 3 T MRI with
1.5 T MRI in the field of neuroradiology. Interestingly, the
authors found no convincing evidence of improved image
quality, diagnostic accuracy, or reduced total examination
times using 3 T MRI instead of 1.5 T MRI. These findings
are highly relevant since a new generation of high field MRI
systems operating at 7 T has recently been introduced.
Key Points
• Higher magnetic field strengths do not necessarily lead to
a better diagnostic accuracy.
• Disadvantages of high field MR systems have to be
considered in clinical practice.
• Higher field strengths are needed for functional imaging,
spectroscopy, etc.
• Disappointingly there are few direct comparisons of 1.5
and 3 T MRI.
• Whether the next high field MR generation (7 T) will
improve diagnostic accuracy has to be investigated.
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Since approval by the U.S. Food and Drug Administra-
tion (FDA) more than a decade ago, the installation and
use of high field MR systems operating at 3 Tesla (T)
for research purposes and more recently in clinical prac-
tice have dramatically increased. Based on the theoretical
substantial increase in signal-to-noise ratio (SNR) com-
pared to standard magnetic field strengths (1.5 T and
below), the most relevant sales pitch by vendors was
the achievement of better image quality and the ability
to reduce MR data acquisition and overall examination
times when using 3 T. Extensive research reflected in a
tremendous number of original articles has been per-
formed and collectively demonstrates the benefits but
also challenges of 3 T MRI. Particularly in the field of
neuroradiology, the benefits of 3 T imaging seem quite obvi-
ous, not only to obtain better quality routine structural imaging
(e.g. of inflammatory lesions), but especially for applications
with inherently low SNR, such as susceptibility weighted
imaging (SWI), MR angiography (MRA), diffusion tensor
imaging (DTI), functional MRI (fMRI), andMR spectroscopy
[1–5]. However, still up for debate is the crucial question of
the diagnostic relevance of 3 T MRI or in other words “Does
3 TMRI lead to a more sensitive (earlier) and/or more specific
diagnosis of certain diseases?”.
In the current issue of European Radiology, Wardlaw and
colleagues present an exhaustive review of research com-
paring 3 T MRI with 1.5 T MRI in the field of neuroradiol-
ogy [6]. The authors evaluated 150 articles assessing a total
of 4,500 subjects published between January 2000 and
October 2010 to find objective evidence that MRI at 3 T
provides higher diagnostic accuracy when compared to
1.5 T. Interestingly, they found no convincing evidence of
improved diagnostic accuracy or reduced total examination
times, both of which constitute the most commonly used
arguments put forward by 3 T manufacturers. In fact, data
directly comparing both field strengths were scarce, and
most studies employed different types and/or generations
of technologies (e.g. coils), different pulse sequences, and
differences in contrast agents. Most studies were small, had
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no randomisation or blinding, and case selection (or exclu-
sion bias) was not reported; beyond that, diagnostic impact
and cost-effectiveness were typically not evaluated.
Although these results may seem surprising at first glance,
they may not be completely unexpected. A direct comparison
of different magnetic field strengths in terms of diagnostic
accuracy is almost impossible. The physical changes occur-
ring when moving to higher magnetic field strength (e.g.
tissue relaxation times, specific absorption rate) make it cru-
cial to adjust the pulse sequences and MR protocol in terms of
repetition and times, but also require a choice between spatial
and temporal resolution to achieve “comparable” conditions
[1, 7]. However, from a formal point of view, it is arguable
whether these conditions are really comparable in terms of a
side-by-side 1.5 versus 3 T comparison. In addition, it is
important to realise that there are other important factors that
substantially contribute to image quality such as coil technol-
ogy, field homogeneity, and multi-transmission technology
[8]. Differences in image quality and MR performance can
even be observed among MR systems of different vendors
operating at the same field strength [9].
Regardless of the fact that a straightforward side-by-side
comparison of 1.5 T and 3 T is very difficult from a meth-
odological point of view, we should ask ourselves whether it
is necessary and useful to formally test all possible differ-
ences in terms of diagnostic accuracy between both field
strengths. Advantages and disadvantages of higher magnetic
field strengths are well known and incontestable. The higher
SNR at 3 T allows imaging at a higher spatial resolution and
the application of parallel imaging techniques as well as
routine use of 3D sequences [10]. It has been conclusively
shown that 3 T shows more (small) inflammatory white and
grey matter lesions and offers a better visualisation of
smaller arterial branches on time-of-flight and contrast-
enhanced MR angiography [11–14]. Despite the fact that
this might not lead to an earlier diagnosis of MS or an earlier
detection of aneurysm or vessel malformation with signifi-
cant therapeutic consequence, (neuro)radiologists would opt
for the better image quality if this came at the same cost and
level of safety, since it makes the reading procedure easier
and more reliable. This is true even for standard clinical
examinations but becomes even more obvious for advanced
and quantitative MR methods substantially benefiting from
improved SNR, such as MR spectroscopy, perfusion MR
(including ASL), and fMRI. Disappointingly, studies deal-
ing with these methods were almost exclusively performed
in the research setting, and in particular, comparative studies
in the clinical setting using these techniques are lacking.
Simply speaking, the situation is (to a certain extent)
comparable to one’s choice of car. The advantages of a
sports car with a lot of horsepower are quite evident. Sport
cars are relatively expensive and need more fuel. However,
they are also faster than other cars and allow you to reach
your destination earlier under pleasant conditions. On the
other hand, in a traffic jam or with bad road infrastructure,
the advantages of a sports car will disappear and the driver
will have to deal with substantial challenges. In those cir-
cumstances, it might be better to drive an economical car or
use public transportation. The described bad street condi-
tions for a sports car correspond to certain 3 T applications
such as spinal cord imaging. Negative bias among the stud-
ies examined includes the absence of 3 T spinal cord data.
The situation is comparable to certain body applications
such as abdomen and pelvis imaging [15]. For those rea-
sons, a small hospital that can afford only a single MR
system should not consider purchasing a 3 T system since
it will not be able cover all clinical demands.
We have to be aware that the high standard of clinical
trial methodology, which is rightly required for treatment
trials proving the superiority of one drug compared to pla-
cebo or another drug, is not simply transferable to diagnostic
imaging comparing one method with another. Technological
improvements are occurring continuously, and it is impos-
sible to systematically compare each new technique with an
existing one, certainly if the advantages are obvious and
come without additional costs or penalties. Only major steps
require validation, and the discussion of the diagnostic ben-
efit of higher magnetic field strength will shift gears when
whole-body ultra-high field MR systems operating at 7 T
need to be compared with 3 T [16, 17]. Once again, certain
advantages of 7 T are quite obvious and promising even in
the clinical setting. However, the 3 T sports car mutates into
a 7 T Formula One racing car, which makes daily use even
more challenging. The major question is under what circum-
stances are the increased costs of 7 T and the inherent
limitations in coverage and safety outweighed by diagnostic
benefits.
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